Lunate Capital Ltd

CIK: 0002056786Latest portfolio: $264.3M · Q4 2025

Holdings

6

Total Value

$264.3M

New Positions

1

Closed Positions

5

Top Holdings

#StockSharesValue% PortfolioChangeType
1
RVMDREVOLUTION MEDICINES INC
2,196,200$174.9M66.20%
2
SAILSAILPOINT INC
3,000,000$60.7M22.97%-24,191,700
3
LINELINEAGE INC
600,000$21.0M7.95%
4
NMRANEUMORA THERAPEUTICS INC.
2,124,143$3.8M1.44%
5
NAVNNAVAN INC
200,000$3.4M1.29%NEW
6
RVMDWREVOLUTION MEDICINES INC
450,000$422K0.16%

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
SAIL3.0M+-24191700

Decreased Positions

No decreased positions

Sector Breakdown

Healthcare0.0% ($1749.3T)
Technology0.0% ($606.9B)
Real Estate0.0% ($21.0M)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Jan 23, 2026$264.3M6
Q3 2025Nov 10, 2025$1.2T10
Q2 2025Jul 17, 2025$178.1B6
Q1 2025Apr 25, 2025$171.2B4

Fund Information

CIK0002056786
Most Recent FilingJan 23, 2026
Number of Filings4

Lunate Capital Ltd is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $264.3M across 6 holdings. The largest position is REVOLUTION MEDICINES INC (RVMD), representing 66.2% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 5 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.